Pet Infectious Disease Research & Development Service
Infectious diseases pose a constant and evolving threat to the health and well-being of companion animals. As the veterinary community seeks more effective preventative and therapeutic solutions, researchers and pharmaceutical companies need a reliable partner to accelerate the development of new treatments. Creative Biolabs offers a comprehensive, preclinical one-stop solution for pet infectious disease research and development. Our services span the entire R&D pipeline, from initial target discovery and in vitro screening to advanced in vivo model development and comprehensive efficacy studies. By partnering with us, you gain access to our deep expertise, advanced technologies, and a commitment to helping you bring life-saving innovations to market faster.
Our Pet Infectious Disease R&D Capabilities
Creative Biolabs delivers fully integrated services to propel your research from discovery to preclinical validation.
Pathogen & Host Target Analysis
- Pathogen characterization, including genotyping, phenotyping, and resistance profiling.
- Investigation of host-pathogen interactions to identify novel therapeutic targets.
- Biomarker discovery for diagnostic development and monitoring therapeutic efficacy.
In Vitro Efficacy Testing
- Antimicrobial susceptibility testing.
- High-throughput screening for antiviral, antibacterial, and antiparasitic compounds.
- Advanced cell-based infection models to assess therapeutic mechanisms of action.
Specialized Infectious Disease Models
- Clinically relevant canine and feline challenge models for key viral and bacterial pathogens.
- Acute, chronic, and latent infection models tailored to your research objectives.
- Use of both immunocompetent and specific-pathogen-free (SPF) systems to evaluate a wide range of therapies.
Preclinical Pharmacology & Safety
- Pharmacokinetic/Pharmacodynamic (PK/PD) modeling to optimize dosing regimens for anti-infectives.
- In vivo efficacy evaluation of vaccines, antimicrobials, and immunomodulators.
- Comprehensive toxicology and safety assessments compliant with regulatory standards.
Veterinary Immunology & Vaccinology
- Robust immunogenicity testing for vaccine candidates, including antibody titer analysis and cell-mediated immunity profiling.
- Cytokine and chemokineprofiling to characterize the immune response to infection and therapy.
- Adjuvant screening and optimization to enhance vaccine potency.
Service Workflow
Our pet infectious disease R&D Service provides comprehensive solutions to study, prevent, and treat infectious diseases in companion animals. We combine in vitro, ex vivo, and in vivo models to deliver actionable insights for vaccine development, therapeutic antibody evaluation, and diagnostic tool development.
| Workflow | Description |
|---|---|
| Project Initiation | We begin with an in-depth consultation to understand your specific therapeutic, target pathogen, and program goals. This initial strategy session ensures our scientific approach is perfectly aligned with your vision. |
| Custom Study Design | Our team of veterinary scientists collaborates with you to develop a robust, customized study protocol. We focus on creating a scientifically rigorous plan with clear endpoints that meets both your research needs and potential regulatory requirements. |
| Execution & Oversight | Your project is managed by a dedicated lead who oversees every aspect of the study. We ensure meticulous execution and provide proactive, transparent communication, keeping you informed with regular progress reports from initiation to completion. |
| Data Analysis & Reporting | Upon study completion, we deliver a final, comprehensive report. This includes high-quality raw data, in-depth statistical analysis, and expert interpretation to provide clear insights and support your critical go/no-go decisions. |
Our Advantages
Applications
Creative Biolabs provides the flexibility to support your needs, whether you require a single specialized assay or a fully integrated preclinical program. Our expert project management ensures seamless execution and communication at every stage. We have extensive experience advancing a wide range of therapeutic modalities, including:
- Small Molecule Antibiotics & Antivirals
- Therapeutic Monoclonal Antibodies
- Subunit, mRNA, and Viral Vector Vaccines
- Bacteriophage Therapies
- Novel Immunomodulators
Partner with Creative Biolabs
Choosing Creative Biolabs means gaining a strategic ally dedicated to the fight against infectious diseases in companion animals. By leveraging our specialized services, you can accelerate your development timelines, mitigate risks, and bring groundbreaking therapies to the pets who need them. Let us help you translate your scientific discoveries into tangible health outcomes.
Ready to advance your anti-infective program? Contact Creative Biolabs today to discuss your research needs. Our team of experts is ready to build a tailored solution to drive your project forward.